Últimas noticias sobre Annovis Bio (NYSE:ANVS) Bolsa

ANNOVIS BIO

Annovis Bio

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Annovis Bio Inc

Health Care

Press Releases

Annovis to Host Patients' Live Forum on February 27, 2025

News

Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment

Earnings

Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program

Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE

Management

Annovis Bio Appoints Hui Liu as Director of Biostatistics

Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results

Annovis to Host Webinar and Live Q&A on June 24, 2025

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance

Annovis to Attend the AAIC 2025 with Four Poster Presentations

ANVS

ABVC BioPharma

Acrivon Therapeutics, Inc. - Common Stock

Acrivon Therapeutics

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Aligos Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics

Celularity

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

OS Therapies

PepGen

Pluri

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

RenovoRx

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals

Shattuck Labs

vTv Therapeutics Inc. - Class A Common Stock

Comments

Annovis Bio

Noticias

Últimas noticias sobre Annovis Bio (NYSE:ANVS) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL